O

OncoMedX – Oncology Pharmaceutical Consulting (Private limited company)

BE 0738.436.452 Active ●Saffelbergstraat 19B, 1750 Lennik

OncoMedX – Oncology Pharmaceutical Consulting is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0738.436.452. It was founded on 26-11-2019. Its registered office is in Lennik. Its main activity is: Activities of head offices and management consultancy. Its annual accounts for 2025 report equity of € -23 172 and a loss of € 96. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 16-10-2026.

Company information

Status
Active
Enterprise number
BE 0738.436.452
VAT registered
Yes
Founded
26-11-2019
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Saffelbergstraat 19B, 1750 Lennik
Main activity
Activities of head offices and management consultancy
NACE activities
70200 Activités de conseil pour les affaires et autre conseil de gestion
73300 Activités de conseil en relations publiques et communication

Key figures of OncoMedX – Oncology Pharmaceutical Consulting

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -96-219 %€ -30+75 %€ -122+99 %€ -8 720
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ -23 1720 %€ -23 0760 %€ -23 046-1 %€ -22 924
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 6 701-6 %€ 7 146+4 %€ 6 848-73 %€ 25 449
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -66--€ 587
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade B, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Lennik.

CompanyTown
Kasteel van Lennik 1750 Lennik
MOLENS SINT MARTINUS - MOULINS SINT MARTIN 1750 Lennik
FINGEVER 1750 Lennik
JUSTINES 1750 Lennik
J&I Pauwels 1750 Lennik
POWERCELL 1750 Lennik
AMFORTIS 1750 Lennik
GALMART - VAN LATHEM 1750 Lennik
Looking for more information about OncoMedX – Oncology Pharmaceutical Consulting?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is OncoMedX – Oncology Pharmaceutical Consulting still active? Yes. The Crossroads Bank for Enterprises lists OncoMedX – Oncology Pharmaceutical Consulting as active.

What is the VAT number of OncoMedX – Oncology Pharmaceutical Consulting? The VAT number of OncoMedX – Oncology Pharmaceutical Consulting is BE 0738.436.452.

When was OncoMedX – Oncology Pharmaceutical Consulting founded? OncoMedX – Oncology Pharmaceutical Consulting was founded on 26-11-2019.

What is the address of OncoMedX – Oncology Pharmaceutical Consulting? The current registered office of OncoMedX – Oncology Pharmaceutical Consulting is Saffelbergstraat 19B, 1750 Lennik.

When did OncoMedX – Oncology Pharmaceutical Consulting last file annual accounts? The latest annual accounts of OncoMedX – Oncology Pharmaceutical Consulting were filed on 26-08-2026.

Does OncoMedX – Oncology Pharmaceutical Consulting file its annual accounts on time? Yes. OncoMedX – Oncology Pharmaceutical Consulting filed its annual accounts within the legal deadline for each of its last 4 financial years.

Is OncoMedX – Oncology Pharmaceutical Consulting financially healthy? Addrly gives OncoMedX – Oncology Pharmaceutical Consulting a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is OncoMedX – Oncology Pharmaceutical Consulting profitable? The annual accounts of OncoMedX – Oncology Pharmaceutical Consulting for 2025 show a loss of € 96.

What is the equity of OncoMedX – Oncology Pharmaceutical Consulting? The equity of OncoMedX – Oncology Pharmaceutical Consulting was € -23 172 at the close of the 2025 financial year.

Who are the directors of OncoMedX – Oncology Pharmaceutical Consulting? The annual accounts of OncoMedX – Oncology Pharmaceutical Consulting record 1 mandate. The name, role and dates are visible with a free account.

Can OncoMedX – Oncology Pharmaceutical Consulting receive Peppol e-invoices? Yes. OncoMedX – Oncology Pharmaceutical Consulting is registered on the Peppol network and can receive structured electronic invoices.

What does OncoMedX – Oncology Pharmaceutical Consulting do? The main activity of OncoMedX – Oncology Pharmaceutical Consulting is: Activities of head offices and management consultancy.

Sources

How Addrly builds and refreshes this data